Tuesday - August 4, 2026
VA launches trial of GLP-1 treatment for alcohol use disorder
July 30, 2026
WASHINGTON, July 30 -- The U.S. Department of Veterans Affairs issued the following news release:

* * *

VA launches trial of GLP-1 treatment for alcohol use disorder

*

WASHINGTON -The U.S. Department of Veterans Affairs today announced a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use disorder (AUD).

Currently, more than 400,000 Veterans natio . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products